Related Experiment Video
Updated: May 28, 2026
09:45
Generation of 3D Whole Lung Organoids from Induced Pluripotent Stem Cells for Modeling Lung Developmental Biology and Disease
Published on: April 12, 2021
Progenitor cells in pulmonary vascular remodeling
Michael E Yeager1, Maria G Frid, Kurt R Stenmark
1Department of Pediatrics and Critical Care, University of Colorado at Denver and Health Sciences Center, Colorado, USA.
Pulmonary Circulation
|October 29, 2011
Summary
Pulmonary hypertension involves vascular remodeling driven by progenitor cells. Understanding these cells
Area of Science:
- Cardiovascular Research
- Cell Biology
- Regenerative Medicine
Background:
- Pulmonary hypertension (PH) involves cellular and structural changes in pulmonary arteries.
- Key changes include intimal thickening, medial hypertrophy, adventitial fibroproliferation, and smooth muscle extension.
- Enhanced presence of alpha-smooth muscle actin (α-SM-actin+) cells, inflammatory cells, and distinct endothelial cells contributes to PH pathology.
Purpose of the Study:
- To review the role of vascular progenitor cells in pulmonary vascular remodeling.
- To explore the origins and molecular mechanisms of cell accumulation in PH.
- To highlight the potential of progenitor cell research for novel PH therapies.
Main Methods:
- Literature review of studies on vascular progenitor cells in pulmonary hypertension.
- Analysis of data supporting the contribution of endothelial progenitor cells, smooth muscle progenitor cells, pericytes, and fibrocytes.
- Examination of resident and bone marrow-derived progenitor cell roles.
Main Results:
- Both resident vascular progenitor cells and bone marrow-derived progenitor cells contribute to vascular remodeling in PH.
- Resident progenitors can differentiate into myofibroblastic, endothelial, or hematopoietic cells.
- Circulating progenitors are recruited to sites of vascular injury, adopting endothelial and smooth muscle phenotypes.
Conclusions:
- Vascular progenitor cells play a significant role in the pathogenesis of pulmonary hypertension.
- Further understanding of progenitor cell modulation of pulmonary vascular remodeling is crucial.
- This knowledge may lead to new therapeutic strategies beyond current treatments for PH.
Related Concept Videos
01:30Pulmonary Hypertension: Classification and Pathogenesis
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
01:24Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
01:19Multipotency of Hematopoietic Stem Cells
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
01:34Production of Formed Elements
Hemangioblasts are multipotent stem cells originating from the mesoderm. They give rise to hematopoietic stem cells (HSCs), which undergo hematopoiesis to produce all the formed elements of blood. This process is regulated by a complex network of hematopoietic growth factors, including transcription factors, growth factors, and cytokines. These factors stimulate the HSCs to divide and differentiate, though some HSCs remain undifferentiated to maintain a self-renewing pool.
Most HSCs commit to...
Most HSCs commit to...
01:07Development of Blood Vessels
The development of the vascular system in a fetus is a complex and intricate process that begins as early as 15 to 16 days post-conception. This process starts outside the embryo, specifically in the mesoderm of the yolk sac, chorion, and connecting stalk. Approximately two days later, the formation of blood vessels occurs within the embryo itself.
The initial formation of this system is facilitated by the small amount of yolk present in the ovum and yolk sac. Blood vessels originate from...
The initial formation of this system is facilitated by the small amount of yolk present in the ovum and yolk sac. Blood vessels originate from...
01:10Mechanism of Angiogenesis
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...